HK:2563 Stock Latest News
Company AnnouncementsBeijing Biostar Advances Oral Utidelone to Phase III in HER2-Negative Breast Cancer1w ago2563
Company AnnouncementsBeijing Biostar Pharmaceuticals Doubles Revenue and Narrows Losses in First Half of 20262M ago2563
Company AnnouncementsBeijing Biostar Pharmaceuticals Sets Board Meeting to Review Interim Results and Dividend2M ago2563
Company AnnouncementsBeijing Biostar completes HK$4.00-per-share subscription, expanding equity base3M ago2563
Company AnnouncementsBeijing Biostar Wins Shareholder Backing for Capital Mandates and Governance Changes at AGM4M ago2563
Company AnnouncementsBeijing Biostar Pharmaceuticals Clarifies Board and Committee Roles in Governance Update4M ago2563Company AnnouncementsBeijing Biostar Pharmaceuticals Withdraws Three Resolutions From 2026 AGM Agenda4M ago2563
Company AnnouncementsBeijing Biostar Sets 2026 AGM to Approve 2025 Results and Seek New Share Issuance Mandate5M ago2563
Company AnnouncementsBeijing Biostar’s Utidelone Data Selected for 2026 ASCO as Trials Show Promising Efficacy and Safety5M ago2563
Company AnnouncementsBeijing Biostar Tightens Employee Share Option Limit After Clarification5M ago2563
Company AnnouncementsBeijing Biostar clarifies pricing and timetable for discounted share subscription5M ago2563
Company AnnouncementsBeijing Biostar Pharmaceuticals Plans Discretionary H-Share Buy-Back to Signal Confidence5M ago2563
Company AnnouncementsBeijing Biostar Boosts Strategic Ties With Baheal via HK$100 Million Share Subscription5M ago2563Company AnnouncementsBeijing Biostar Plans 10‑Year Share Option Scheme to Strengthen Long‑Term Incentives5M ago2563
Company AnnouncementsBeijing Biostar Reshapes Board to Regain HKEX Compliance After Director Resigns6M ago2563
Company AnnouncementsBeijing Biostar Pharmaceuticals Updates Board and Committee Structure After Director Resignation6M ago2563- Company AnnouncementsBeijing Biostar Narrows Loss as Utidelone Oncology Pipeline Advances Globally7M ago2563
Company AnnouncementsBeijing Biostar Warns of Possible Qualified Audit Opinion Over Investment Fund7M ago2563- Company AnnouncementsBeijing Biostar Warns of Expected Qualified Audit Opinion for 2025 Results7M ago2563
Company AnnouncementsBeijing Biostar Delays Board Meeting to Finalise 2025 Annual Results7M ago2563Company AnnouncementsBeijing Biostar Sets March Board Meeting to Approve 2025 Results and Mull Dividend7M ago2563
Company AnnouncementsBeijing Biostar Secures CSRC Filing for H Share Full Circulation Plan8M ago2563